×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OLMA – olema pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OLMA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/17
04:30 pm
olma
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Low
Report
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
3/17
12:30 pm
olma
Olema Pharmaceuticals (OLMA) had its price target raised by Citigroup Inc. from $60.00 to $62.00. They now have a "buy" rating on the stock.
Low
Report
Olema Pharmaceuticals (OLMA) had its price target raised by Citigroup Inc. from $60.00 to $62.00. They now have a "buy" rating on the stock.
3/17
09:03 am
olma
Olema Pharmaceuticals (OLMA) had its price target lowered by Guggenheim from $40.00 to $38.00. They now have a "buy" rating on the stock.
Medium
Report
Olema Pharmaceuticals (OLMA) had its price target lowered by Guggenheim from $40.00 to $38.00. They now have a "buy" rating on the stock.
3/16
07:11 pm
olma
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch [Yahoo! Finance]
Medium
Report
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch [Yahoo! Finance]
3/16
07:43 am
olma
Olema Pharmaceuticals GAAP EPS of -$0.50 beats by $0.01 [Seeking Alpha]
Medium
Report
Olema Pharmaceuticals GAAP EPS of -$0.50 beats by $0.01 [Seeking Alpha]
3/16
07:00 am
olma
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
High
Report
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
3/12
08:44 pm
olma
A Look At Olema Pharmaceuticals (OLMA) Valuation After Roche Breast Cancer Trial Setback And Share Price Pullback [Yahoo! Finance]
Low
Report
A Look At Olema Pharmaceuticals (OLMA) Valuation After Roche Breast Cancer Trial Setback And Share Price Pullback [Yahoo! Finance]
3/10
11:29 am
olma
H.C. Wainwright does not see direct read from Roche miss to Olema's OPERA-02 [Yahoo! Finance]
Medium
Report
H.C. Wainwright does not see direct read from Roche miss to Olema's OPERA-02 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/16/2026
07:00 am
olma
olema pharmaceuticals, inc.
BEAT
Report
11.8%
olema pharmaceuticals, inc.
11/10/2025
07:00 am
olma
olema pharmaceuticals, inc.
MISS
Report
6.1%
olema pharmaceuticals, inc.
8/11/2025
04:01 pm
olma
olema pharmaceuticals, inc.
MISS
Report
8.5%
olema pharmaceuticals, inc.
5/13/2025
04:01 pm
olma
olema pharmaceuticals, inc.
BEAT
Report
-3.8%
olema pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/16
04:04 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Medium
Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
3/16
12:44 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low
Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
3/16
07:19 am
olma
Form S-8 Olema Pharmaceuticals,
High
Report
Form S-8 Olema Pharmaceuticals,
3/16
07:11 am
olma
Form 10-K Olema Pharmaceuticals, For: Dec 31
High
Report
Form 10-K Olema Pharmaceuticals, For: Dec 31
3/16
07:05 am
olma
Form 8-K Olema Pharmaceuticals, For: Mar 16
High
Report
Form 8-K Olema Pharmaceuticals, For: Mar 16
3/11
04:20 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Medium
Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
3/10
12:28 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Medium
Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
3/9
03:16 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Neutral
Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: